Following a 39% Q2 EPS miss and negative free cash flow, Tesla's stock has dropped 27% year-to-date, currently trading at $328.58, 20% below its 52-week high. While Wall Street's consensus target is $398, some analysts believe the company's 2027 pipeline, including Optimus, Cybercab, and Robotaxi, is largely unpriced. They project a potential 52.2% gain to $500 by the end of 2027 if these products scale, citing catalysts like the Terafab semiconductor campus, Megapack 3 production, Robotaxi expansion, and a 56% year-over-year increase in FSD subscriptions to 1.48 million. However, risks include capital expenditures remaining above $25 billion without commensurate revenue leverage and free cash flow staying negative into 2027.